Related references
Note: Only part of the references are listed.The interactions between DNA methylation machinery and long non-coding RNAs in tumor progression and drug resistance
Mokhtar Jawad Al-Imam et al.
DNA REPAIR (2023)
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li et al.
CANCER CELL (2023)
Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical Cancer
Kaidi Zhao et al.
FRONTIERS IN GENETICS (2022)
Surgical and focal treatment for metastatic renal cell carcinoma: A literature review
Sei Naito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2022)
Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
Qi Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established
Shuangqing Chen et al.
JOURNAL OF INFLAMMATION RESEARCH (2022)
Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway
Yijing Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma
Meng-Yu Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Effects of Inflammation on the Immune Microenvironment in Gastric Cancer
Weidan Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs
Kai Wang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma
Zhijin Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Oncometabolites in renal cancer
Cissy Yong et al.
NATURE REVIEWS NEPHROLOGY (2020)
Integrative Analysis of Methylation and Transcriptome Identified Epigenetically Regulated lncRNAs With Prognostic Relevance for Thyroid Cancer
Qiuying Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis
Chunyan Luan et al.
ONCOTARGETS AND THERAPY (2020)
Integrative Analysis of Differential lncRNA/mRNA Expression Profiling in Helicobacter pylori Infection-Associated Gastric Carcinogenesis
Nianshuang Li et al.
FRONTIERS IN MICROBIOLOGY (2020)
Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma
Zhujuan Wang et al.
CELL CYCLE (2020)
LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1
Fei Yan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The small peptide world in long noncoding RNAs
Seo-Won Choi et al.
BRIEFINGS IN BIOINFORMATICS (2019)
A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
Katiuscha Merath et al.
JAMA SURGERY (2019)
MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5
Haimin Zhang et al.
CELL PROLIFERATION (2019)
Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
Lynda Vuong et al.
CANCER DISCOVERY (2019)
Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis
Clara Lorente-Sorolla et al.
GENOME MEDICINE (2019)
Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity
Joshua D. Ochocki et al.
CELL METABOLISM (2018)
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The Role of DNA Methylation in Renal Cell Carcinoma
Brittany N. Lasseigne et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805
Lucia B. Jilaveanu et al.
CLINICAL CANCER RESEARCH (2018)
MALAT1-mediated tumorigenesis
Jianghua Liu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
Natural antisense RNA promotes 3' end processing and maturation of MALAT1 lncRNA
Xinying Zong et al.
NUCLEIC ACIDS RESEARCH (2016)
Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis
Gan-Shen Yu et al.
Asian Pacific Journal of Cancer Prevention (2015)
Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma
Jiang Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma
Hai-min Zhang et al.
TUMOR BIOLOGY (2015)
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Tony Gutschner et al.
CANCER RESEARCH (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Share Paper
